Variant report
Variant | esv3451160 |
---|---|
Chromosome Location | chr22:27580202-27582200 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs6005321 | chr22:27580224-27580225 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs527526910 | chr22:27580238-27580239 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs374959247 | chr22:27580256-27580257 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs549250299 | chr22:27580304-27580305 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs141935848 | chr22:27580338-27580339 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs567559041 | chr22:27580356-27580357 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs376725234 | chr22:27580376-27580377 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs117840867 | chr22:27580415-27580416 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs9625174 | chr22:27580426-27580427 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs550977023 | chr22:27580509-27580510 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs569188848 | chr22:27580529-27580530 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs539533246 | chr22:27580533-27580534 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs193178513 | chr22:27580593-27580594 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs148365605 | chr22:27580637-27580638 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs534130129 | chr22:27580638-27580639 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs555600773 | chr22:27580643-27580644 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs9613393 | chr22:27580688-27580689 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs185040169 | chr22:27580689-27580690 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs143328227 | chr22:27580711-27580712 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs556108024 | chr22:27580762-27580763 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs552946519 | chr22:27580851-27580852 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs577606347 | chr22:27580870-27580871 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs545118491 | chr22:27580872-27580873 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs560290351 | chr22:27580876-27580877 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs376290353 | chr22:27580877-27580878 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs189508077 | chr22:27580884-27580885 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs560998732 | chr22:27580885-27580886 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs181773999 | chr22:27580903-27580904 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs535607231 | chr22:27580916-27580917 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs183964170 | chr22:27580931-27580932 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs201839503 | chr22:27580960-27580961 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs12329959 | chr22:27580980-27580981 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs188247788 | chr22:27581004-27581005 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs538129955 | chr22:27581049-27581050 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs28454067 | chr22:27581056-27581057 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs28627623 | chr22:27581075-27581076 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs28567768 | chr22:27581079-27581080 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs575141266 | chr22:27581094-27581095 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs28380707 | chr22:27581102-27581103 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs28429545 | chr22:27581104-27581105 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs533201422 | chr22:27581108-27581109 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs116193196 | chr22:27581118-27581119 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs28394177 | chr22:27581123-27581124 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs534097223 | chr22:27581126-27581127 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs375606791 | chr22:27581139-27581140 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs369148457 | chr22:27581140-27581141 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs10671816 | chr22:27581159-27581160 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs549531952 | chr22:27581208-27581209 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs567797871 | chr22:27581258-27581259 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs538520448 | chr22:27581283-27581284 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Velocardiofacial syndrome | 20111667 | CNVD |
Medulloblastoma | 21979893 | CNVD |
sporadic solitary meningiomas | 19589153 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Congenital heart defect | 22511896 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Seminomas | 18059402 | CNVD |
Cancer | 16751803 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Metachromatic leukodystrophy | 18421352 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Breast cancer | 21858162 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 16608533 | CNVD |
Melanoma | 18172304 | CNVD |
Ovarian cancer | 22174824 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21785460 | CNVD |
Medullary thyroid carcinoma | 18765511 | CNVD |
Lung cancer | 18438408 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
abnormal development | 18461090 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16272173 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17142309 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Cat eye syndrome | 16708226 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Schizophrenia | 19521646 | CNVD |
Schizophrenia | 18990708 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr22:27571800-27598600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr22:27572400-27582000 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
3 | chr22:27576400-27581200 | Weak transcription | Fetal Brain Male | brain |
4 | chr22:27576800-27581600 | Weak transcription | Fetal Brain Female | brain |
5 | chr22:27579000-27580400 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
6 | chr22:27580000-27582200 | Weak transcription | Brain Germinal Matrix | brain |
7 | chr22:27580000-27585000 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
8 | chr22:27580400-27584800 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
9 | chr22:27581200-27583400 | Enhancers | Fetal Brain Male | brain |
10 | chr22:27581600-27582200 | Enhancers | Fetal Stomach | stomach |
11 | chr22:27581600-27583600 | Enhancers | Fetal Brain Female | brain |
12 | chr22:27582000-27582200 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
13 | chr22:27582000-27583600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
14 | chr22:27582200-27583200 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
15 | chr22:27582200-27583400 | Enhancers | Brain Germinal Matrix | brain |
16 | chr22:27582200-27583600 | Enhancers | HUES48 Cell Line | embryonic stem cell |